MiNK Therapeutics, Inc. , a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases.
Mink Therapeutics stock last closed at $7.45, down 5.19% from the previous day, and has decreased 24.73% in one year. It has overperformed other stocks in the Biotechnology industry by 0.52 percentage points. Mink Therapeutics stock is currently +63.42% from its 52-week low of $4.56, and -45.96% from its 52-week high of $13.79.
As of Apr 30, 2025, there are 3.97M INKT shares outstanding. The market value of INKT is $29.56M. In the last 24 hours, 1591 INKT shares were traded.
How to Buy Mink Therapeutics Stock
Wondering how to invest in Mink Therapeutics stock? Here's how.
Decide where to buy Mink Therapeutics stock: You need to decide on an online brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you figure out where to buy Mink Therapeutics stock.
Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
Deposit funds into your brokerage account: Select your method of payment and add your information.
Evaluate Mink Therapeutics stock: The Mink Therapeutics ticker symbol is INKT. Is Mink Therapeutics stock a good investment? Should you buy shares of INKT? How do INKT's underlying business fundamentals look? Do top analysts think Mink Therapeutics is a good buy? Why has INKT's stock price moved recently? (Hint: Our stock analysis website can help you evaluate if INKT is a good stock to buy).
Make your INKT buy order: Decide if you will purchase INKT shares at the current market price or use a limit order to purchase INKT shares at a specific price.
Keep an eye on your INKT investment: Create a watchlist to watch your investment in Mink Therapeutics shares.
Step 1: Decide where to buy Mink Therapeutics stock
You need a brokerage account to access the NASDAQ market and buy INKT stock.
A brokerage account is an investment account that allows you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
Based on our experience, eToro is the best stock brokerage. eToro gives you:
Invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
Access to global markets: From Tech to Industrials, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by opening an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create a brokerage account
Now that you've selected the best brokerage, you need to fill out some personal info so you can invest in INKT stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Mink Therapeutics stock
After you have figured out the best place to buy Mink Therapeutics stock, it's absolutely critical to analyze their stock before you invest, so you actually wrap your head around the risk as well as the opportunity.
Overview of key INKT info
INKT Price
$7.45
1w %
-2.08%
1y %
-24.73%
5y %
N/A
P/E
-2.61x
P/B
-1.51x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$10.78M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$29.56M
Next Earnings
Jun 12, 2025
Next Dividend
N/A
Mink Therapeutics Due Diligence Score
WallStreetZen was built to help everyday investors do more in-depth fundamental analysis.
Last year, INKT revenue was $0.00. Over the last 5 year, INKT's revenue has gone up by -100% per year. This was slower than the Biotechnology industry average of 45.66%.
No, Mink Therapeutics doesn't provide an income stream by paying out dividends.
Get opinions from other investors
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Make your INKT buy order
There are two primary types of orders:
Market order: A market order is an order to buy or sell a security at the best available price. Market orders are generally the easiest way to buy.
Limit order: A limit order allows you to buy or sell a stock at a specific price (or better). If you want to be certain you're buying or selling at an exact dollar amount limit, place a limit order.
Hit the Open Trade button and your broker will execute the order.
If you want more assistance investing in stocks on eToro, watch the helpful video below:
How much does it cost to buy one Mink Therapeutics share?
As of Apr 30, 2025, it costs $7.45 to buy one share of Mink Therapeutics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $3, you can buy 0.403 shares of INKT.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.